CoChat

Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment

Fernández-Barat, Laia, Ciofu, Oana, Kragh, Kasper N., Pressler, Tania, Johansen, Ulla, Motos, Anna, Torres, Antoni, Hoiby, Niels · 2017 · Journal of Cystic Fibrosis
Cited by 50

The DOI matches its Crossref record.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcf.2016.08.005

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 28

  1. Emerson, 2002, Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis, Pediatr Pulmonol, 34, 91, 10.1002/ppul.10127 · DOI · Paper page
  2. Qin, 2012, Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients, Antimicrob Agents Chemother, 56, 5971, 10.1128/AAC.01371-12 · DOI · Paper page
  3. Frederiksen, 1996, Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment, Pediatr Pulmonol, 21, 153, 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R · DOI · Paper page
  4. Giwercman, 1990, Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains, J Antimicrob Chemother, 26, 247, 10.1093/jac/26.2.247 · DOI
  5. Klockgether, 2013, Intraclonal diversity of the Pseudomonas aeruginosa cystic fibrosis airway isolates TBCF10839 and TBCF121838: distinct signatures of transcriptome, proteome, metabolome, adherence and pathogenicity despite an almost identical genome sequence, Environ Microbiol, 15, 191, 10.1111/j.1462-2920.2012.02842.x · DOI
  6. Feliziani, 2010, Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections, Plos One, 5, 1932, 10.1371/journal.pone.0012669 · DOI · Paper page
  7. Oliver, 2000, High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection, Science, 288, 1251, 10.1126/science.288.5469.1251 · DOI · Paper page
  8. Doring, 2000, Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus, Eur Respir J, 16, 749, 10.1034/j.1399-3003.2000.16d30.x · DOI · Paper page
  9. Ciofu, 1994, Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center, APMIS, 102, 674, 10.1111/j.1699-0463.1994.tb05219.x · DOI
  10. Ciofu, 2013, P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs, J Cyst Fibros, 12, 729, 10.1016/j.jcf.2013.02.004 · DOI
  11. Kragh, 2014, Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients, Infect Immun, 82, 4477, 10.1128/IAI.01969-14 · DOI · Paper page
  12. Fernandez-Barat, 2012, Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy, FEMS Immunol Med Microbiol, 65, 309, 10.1111/j.1574-695X.2012.00961.x · DOI
  13. Pitt, 2003, Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents, Thorax, 58, 794, 10.1136/thorax.58.9.794 · DOI
  14. Mogayzel, 2013, Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health, Am J Respir Crit Care Med, 187, 680, 10.1164/rccm.201207-1160OE · DOI · Paper page
  15. Ciofu, 2001, Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting, J Antimicrob Chemother, 48, 391, 10.1093/jac/48.3.391 · DOI
  16. Lebeaux, 2014, Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics, Microbiol Mol Biol Rev, 78, 510, 10.1128/MMBR.00013-14 · DOI · Paper page
  17. Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 21, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  18. Ciofu, 2005, Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation, Antimicrob Agents Chemother, 49, 2276, 10.1128/AAC.49.6.2276-2282.2005 · DOI · Paper page
  19. Macia, 2011, Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment, Antimicrob Agents Chemother, 55, 5230, 10.1128/AAC.00617-11 · DOI · Paper page
  20. Harmer, 2013, Modulation of gene expression by Pseudomonas aeruginosa during chronic infection in the adult cystic fibrosis lung, Microbiology, 159, 2354, 10.1099/mic.0.066985-0 · DOI
  21. Winstanley, 2016, Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections, Trends Microbiol, 24, 327, 10.1016/j.tim.2016.01.008 · DOI · Paper page
  22. McCaughey, 2013, Fosfomycin and tobramycin in combination downregulate nitrate reductase genes narG and narH, resulting in increased activity against Pseudomonas aeruginosa under anaerobic conditions, Antimicrob Agents Chemother, 57, 5406, 10.1128/AAC.00750-13 · DOI
  23. Kolpen, 2010, Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis, Thorax, 65, 57, 10.1136/thx.2009.114512 · DOI · Paper page
  24. Worlitzsch, 2002, Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients, J Clin Invest, 109, 317, 10.1172/JCI0213870 · DOI · Paper page
  25. Hoffman, 2009, Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression, J Cyst Fibros, 8, 66, 10.1016/j.jcf.2008.09.006 · DOI · Paper page
  26. Fothergill, 2010, Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations, J Med Microbiol, 59, 472, 10.1099/jmm.0.015875-0 · DOI
  27. Clark, 2015, Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis, Sci Rep, 5, 10932, 10.1038/srep10932 · DOI
  28. Mowat, 2011, Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections, Am J Respir Crit Care Med, 183, 1674, 10.1164/rccm.201009-1430OC · DOI · Paper page

Metadata

Authors
Fernández-Barat, L., Ciofu, O., Kragh, K. N., Pressler, T., Johansen, U., Motos, A., Torres, A., & Hoiby, N.
Venue
Journal of Cystic Fibrosis
Publisher
Elsevier BV
Published
2017-03
Volume
16
Issue
2
Pages
222-229
ISSN
1569-1993
Cited by
50
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.